Amgen (NASDAQ:AMGN): Q2 EPS of $1.29 beats by $0.13. Revenue of $3.7B (-1%) vs. $3.6B. Raises...

Jul. 27, 2009 4:07 PM ETAmgen Inc. (AMGN)AMGNBy: Jason Aycock, SA News Editor2 Comments

Amgen (NASDAQ:AMGN): Q2 EPS of $1.29 beats by $0.13. Revenue of $3.7B (-1%) vs. $3.6B. Raises full-year EPS guidance to $4.80-4.95 vs. $4.57. Shares +2.5% AH. (PR)

Recommended For You

Comments (2)

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

Vieira Trading

27 Jul. 2009

Comments (127)

Beyond Trading on (AMGN) "great companies are like great investors; you can get it wrong once or twice but the substance is there long term"

Vieira Trading

27 Jul. 2009

Comments (127)

we're still holding to our recommendation from $52 long on this one; this is good money in you pocket long term